Prognostic Value of Functional Capacity in Different Exercise Protocols.


Journal

Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524

Informations de publication

Date de publication:
07 07 2020
Historique:
pubmed: 25 6 2020
medline: 10 3 2021
entrez: 25 6 2020
Statut: ppublish

Résumé

Background Functional capacity is associated with mortality, although the prognostic value of achieved estimated metabolic equivalents (METs) across various exercise protocols is not established. We sought to determine whether achieved METs had different prognostic implications according to the protocol employed. Methods and Results From 1991 to 2015, we identified 120 705 consecutive patients from a stress testing registry who underwent the following 7 different standardized exercise protocols: Bruce, modified Bruce, Cornell 0%, Cornell 5%, Cornell 10%, Naughton, and modified Naughton. The primary outcome was all-cause mortality. There were 74 953 Bruce, 8368 modified Bruce, 2648 Cornell 0%, 9972 Cornell 5%, 20 425 Cornell 10%, 1226 Naughton, and 3113 modified Naughton protocols. During a mean follow-up of 8.7 years, a total of 8426 deaths (6.9%) occurred. When compared with the Bruce protocol, after multivariable adjustment for clinical risk factors, medications, and functional capacity, test protocol was independently associated with mortality (modified Naughton [hazard ratio (HR), 2.51; 95% CI, 2.26-2.8], Naughton [HR, 1.79; 95% CI, 1.57-2.04], Cornell 0% [HR, 1.79; 95% CI, 1.59-2.01], modified Bruce [HR, 1.62; 95% CI, 1.48-1.76], Cornell 5% [HR, 1.61; 95% CI, 1.47-1.75], and Cornell 10% [HR, 1.32; 95% CI, 1.22-1.42]). Across all protocols, higher estimated METs were associated with lower mortality, although the equivalent METs achieved were associated with a worse prognosis in less-demanding protocols. Conclusions Higher estimated METs are reliably associated with lower mortality in all exercise protocols, although the prognostic value is not transferable across different tests. Consequently, the prognostic value of METs achieved during a stress test should be considered protocol dependent.

Identifiants

pubmed: 32578479
doi: 10.1161/JAHA.119.015986
pmc: PMC7670526
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e015986

Références

Heart. 2016 Mar;102(6):431-7
pubmed: 26732181
Circulation. 1978 Jan;57(1):64-70
pubmed: 618399
Am Heart J. 1973 Apr;85(4):546-62
pubmed: 4632004
N Engl J Med. 2005 Aug 4;353(5):468-75
pubmed: 16079370
Ann Intern Med. 2000 Jun 6;132(11):862-70
pubmed: 10836912
J Am Coll Cardiol. 1984 Mar;3(3):772-9
pubmed: 6229569
J Am Med Inform Assoc. 1997 May-Jun;4(3):233-7
pubmed: 9147342
Circulation. 1990 Nov;82(5):1839-46
pubmed: 2225380
N Engl J Med. 1999 Oct 28;341(18):1351-7
pubmed: 10536127
J Am Coll Cardiol. 1991 May;17(6):1334-42
pubmed: 2016451
J Am Heart Assoc. 2020 Jul 7;9(13):e015986
pubmed: 32578479
Circulation. 2002 Oct 1;106(14):1883-92
pubmed: 12356646
Eur Heart J. 1984 Sep;5(9):752-5
pubmed: 6499863
Prog Cardiovasc Dis. 1986 Jan-Feb;28(4):285-92
pubmed: 3511512
Am J Cardiol. 2017 Aug 15;120(4):688-692
pubmed: 28676154
Circulation. 2001 Oct 16;104(16):1911-6
pubmed: 11602493
Arch Phys Med Rehabil. 1968 Mar;49(3):131-7
pubmed: 4384805
Circulation. 2011 Mar 8;123(9):1010-20
pubmed: 21382903
N Engl J Med. 2002 Mar 14;346(11):793-801
pubmed: 11893790
JAMA Netw Open. 2018 Oct 5;1(6):e183605
pubmed: 30646252
J Electrocardiol. 1986 Oct;19(4):311-8
pubmed: 3540174
J Cardiopulm Rehabil. 2000 Jul-Aug;20(4):235-40
pubmed: 10955264
Am Heart J. 2014 Jan;167(1):77-85
pubmed: 24332145
J Cardiopulm Rehabil Prev. 2007 May-Jun;27(3):149-50
pubmed: 17558195
Eur J Prev Cardiol. 2017 Oct;24(15):1624-1626
pubmed: 28825312
Circulation. 2012 Nov 20;126(21):2465-72
pubmed: 23091065
Am J Cardiol. 1995 May 1;75(14):940-2
pubmed: 7733007
J Am Coll Cardiol. 1993 Jul;22(1):175-82
pubmed: 8509539
Clin Cardiol. 1990 Aug;13(8):555-65
pubmed: 2204507
JAMA. 2000 Sep 20;284(11):1392-8
pubmed: 10989401

Auteurs

Serge C Harb (SC)

Heart and Vascular Institute Cleveland Clinic Cleveland OH.

Pavan Bhat (P)

Heart and Vascular Institute Cleveland Clinic Cleveland OH.

Paul C Cremer (PC)

Heart and Vascular Institute Cleveland Clinic Cleveland OH.

Yuping Wu (Y)

Department of Mathematics and Statistics Cleveland State University Cleveland OH.

Laura J Cremer (LJ)

Case Western Reserve University Cleveland OH.

Stephanie Berger (S)

Heart and Vascular Institute Cleveland Clinic Cleveland OH.

Leslie Cho (L)

Heart and Vascular Institute Cleveland Clinic Cleveland OH.

Venu Menon (V)

Heart and Vascular Institute Cleveland Clinic Cleveland OH.

Martha Gulati (M)

Division of Cardiology University of Arizona College of Medicine Phoenix AZ.

Wael A Jaber (WA)

Heart and Vascular Institute Cleveland Clinic Cleveland OH.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH